Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2006 (2006), Article ID 24502, 6 pages
http://dx.doi.org/10.1155/PPAR/2006/24502
Review Article

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Department of Epidemiology and Biostatistics, University of California, San Francisco, 185 Berry Street, Suite 5700, San Francisco 94107, CA, USA

Received 1 April 2006; Revised 7 July 2006; Accepted 10 July 2006

Copyright © 2006 Ann V. Schwartz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S O Rzonca, L J Suva, D Gaddy, D C Montague, and B Lecka-Czernik, “Bone is a target for the antidiabetic compound rosiglitazone,” Endocrinology, vol. 145, no. 1, pp. 401–406, 2004. View at Publisher · View at Google Scholar · View at PubMed
  2. M A Sorocéanu, D Miao, X-Y Bai, H Su, D Goltzman, and A C Karaplis, “Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis,” Journal of Endocrinology, vol. 183, no. 1, pp. 203–216, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. V Sottile, K Seuwen, and M Kneissel, “Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone),” Calcified Tissue International, vol. 75, no. 4, pp. 329–337, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. C Jennermann, J Triantafillou, D Cowan, B Pennink, K Connolly, and D Morris, “Effects of thiazolidinediones on bone turnover in the rat,” Journal of Bone and Mineral Research, vol. 10, p. S241, 1995, (Abstract S361). View at Google Scholar
  5. L Tornvig, L Mosekilde, J Justesen, E Falk, and M Kassem, “Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice,” Calcified Tissue International, vol. 69, no. 1, pp. 46–50, 2001. View at Publisher · View at Google Scholar · View at PubMed
  6. H III Heath, L J III Melton, and C P Chu, “Diabetes mellitus and risk of skeletal fracture,” New England Journal of Medicine, vol. 303, no. 10, pp. 567–570, 1980. View at Google Scholar
  7. H E Meyer, A Tverdal, and J A Falch, “Risk factors for hip fracture in middle-aged Norwegian women and men,” American Journal of Epidemiology, vol. 137, no. 11, pp. 1203–1211, 1993. View at Google Scholar
  8. L Forsén, H E Meyer, K Midthjell, and T-H Edna, “Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey,” Diabetologia, vol. 42, no. 8, pp. 920–925, 1999. View at Publisher · View at Google Scholar · View at PubMed
  9. A V Schwartz, D E Sellmeyer, K E Ensrud et al., “Older women with diabetes have an increased risk of fracture: a prospective study,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 32–38, 2001. View at Publisher · View at Google Scholar
  10. K K Nicodemus and A R Folsom, “Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women,” Diabetes Care, vol. 24, no. 7, pp. 1192–1197, 2001. View at Publisher · View at Google Scholar
  11. K J Ottenbacher, G V Ostir, M K Peek, J S Goodwin, and K S Markides, “Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults,” Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 57, no. 10, pp. M648–M653, 2002. View at Google Scholar
  12. L A Ahmed, R M Joakimsen, G K Berntsen, V Fønnebø, and H Schirmer, “Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study,” Osteoporosis International, vol. 17, no. 4, pp. 495–500, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. I I De Liefde, M Van Der Klift, C EDH De Laet, P LA Van Daele, A Hofman, and H AP Pols, “Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study,” Osteoporosis International, vol. 16, no. 12, pp. 1713–1720, 2005. View at Publisher · View at Google Scholar · View at PubMed
  14. A H Holmberg, O Johnell, P M Nilsson, J-Å Nilsson, G Berglund, and K Åkesson, “Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women,” Osteoporosis International, vol. 16, no. 12, pp. 2185–2194, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. T HM Keegan, J L Kelsey, S Sidney, and C P Jr Quesenberry, “Foot problems as risk factors of fractures,” American Journal of Epidemiology, vol. 155, no. 10, pp. 926–931, 2002. View at Publisher · View at Google Scholar
  16. E S Strotmeyer, J A Cauley, A V Schwartz et al., “Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study,” Archives of Internal Medicine, vol. 165, no. 14, pp. 1612–1617, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. D A Hanley, J P Brown, A Tenenhouse et al., “Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study,” Journal of Bone and Mineral Research, vol. 18, no. 4, pp. 784–790, 2003. View at Publisher · View at Google Scholar
  18. K E Ensrud, D E Thompson, J A Cauley et al., “Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group,” Journal of the American Geriatrics Society, vol. 48, no. 3, pp. 241–249, 2000, [see comments]. View at Google Scholar
  19. D C Bauer, W S Browner, J A Cauley et al., “Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group,” Annals of Internal Medicine, vol. 118, no. 9, pp. 657–665, 1993. View at Google Scholar
  20. E Barrett-Connor and T L Holbrook, “Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus,” Journal of the American Medical Association, vol. 268, no. 23, pp. 3333–3337, 1992. View at Publisher · View at Google Scholar
  21. P LA Van Daele, R P Stolk, H Burger et al., “Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study,” Annals of Internal Medicine, vol. 122, no. 6, pp. 409–414, 1995. View at Google Scholar
  22. J Verhaeghe, A MH Suiker, T A Einhorn et al., “Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats,” Journal of Bone and Mineral Research, vol. 9, no. 10, pp. 1657–1667, 1994. View at Google Scholar
  23. A V Schwartz, D E Sellmeyer, E S Strotmeyer et al., “Diabetes and bone loss at the hip in older black and white adults,” Journal of Bone and Mineral Research, vol. 20, no. 4, pp. 596–603, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. M T Hannan, D T Felson, B Dawson-Hughes et al., “Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study,” Journal of Bone and Mineral Research, vol. 15, no. 4, pp. 710–720, 2000. View at Publisher · View at Google Scholar
  25. T A Ricci, S B Heymsfield, R N Jr Pierson, T Stahl, H A Chowdhury, and S A Shapses, “Moderate energy restriction increases bone resorption in obese postmenopausal women,” American Journal of Clinical Nutrition, vol. 73, no. 2, pp. 347–352, 2001. View at Google Scholar
  26. H C Looker, W C Knowler, and R L Hanson, “Changes in BMI and weight before and after the development of type 2 diabetes,” Diabetes Care, vol. 24, no. 11, pp. 1917–1922, 2001. View at Publisher · View at Google Scholar
  27. A V Schwartz, T A Hillier, D E Sellmeyer et al., “Older women with diabetes have a higher risk of falls: a prospective study,” Diabetes Care, vol. 25, no. 10, pp. 1749–1754, 2002. View at Publisher · View at Google Scholar
  28. E W Gregg, C M Mangione, J A Cauley et al., “Diabetes and incidence of functional disability in older women,” Diabetes Care, vol. 25, no. 1, pp. 61–67, 2002. View at Publisher · View at Google Scholar
  29. D K Miller, L-Y L Lui, H M III Perry, F E Kaiser, and J E Morley, “Reported and measured physical functioning in older inner-city diabetic African Americans,” Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 54, no. 5, pp. M230–M236, 1999. View at Google Scholar
  30. J T Hanlon, L R Landerman, G G Fillenbaum, and S Studenski, “Falls in African American and white community-dwelling elderly residents,” Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 57, no. 7, pp. M473–M478, 2002. View at Google Scholar
  31. A V Schwartz, “Diabetes mellitus: does it affect bone?,” Calcified Tissue International, vol. 73, no. 6, pp. 515–519, 2003. View at Publisher · View at Google Scholar · View at PubMed
  32. L Mascitelli and F Pezzetta, “Thiazolidinediones and the risk of nontraumatic fractures in patients with diabetes,” Archives of Internal Medicine, vol. 166, no. 1, p. 126, 2006. View at Publisher · View at Google Scholar
  33. D K Wysowski, G Armstrong, and L Governale, “Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001,” Diabetes Care, vol. 26, no. 6, pp. 1852–1855, 2003. View at Publisher · View at Google Scholar
  34. B Lecka-Czernik, I Gubrij, E J Moerman et al., “Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2,” Journal of Cellular Biochemistry, vol. 74, no. 3, pp. 357–371, 1999. View at Publisher · View at Google Scholar
  35. S M Jackson and L L Demer, “Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts,” FEBS Letters, vol. 471, no. 1, pp. 119–124, 2000. View at Publisher · View at Google Scholar
  36. B Lecka-Czernik, E J Moerman, D F Grant, J M Lehmann, S C Manolagas, and R L Jilka, “Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation,” Endocrinology, vol. 143, no. 6, pp. 2376–2384, 2002. View at Publisher · View at Google Scholar
  37. O P Lazarenko, S O Rzonca, L J Suva, and B Lecka-Czernik, “Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat,” Bone, vol. 38, no. 1, pp. 74–84, 2006. View at Publisher · View at Google Scholar · View at PubMed
  38. M E Nuttall, A J Patton, D L Olivera, D P Nadeau, and M Gowen, “Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders,” Journal of Bone and Mineral Research, vol. 13, no. 3, pp. 371–382, 1998. View at Publisher · View at Google Scholar
  39. R Okazaki, M Miura, M Toriumi et al., “Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus,” Endocrine Journal, vol. 46, no. 6, pp. 795–801, 1999. View at Google Scholar
  40. R Okazaki, Y Totsuka, K Hamano et al., “Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 9, pp. 2915–2920, 1997. View at Publisher · View at Google Scholar
  41. S Watanabe, Y Takeuchi, S Fukumoto, H Fujita, T Nakano, and T Fujita, “Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients,” Journal of Bone and Mineral Metabolism, vol. 21, no. 3, pp. 166–171, 2003. View at Publisher · View at Google Scholar · View at PubMed
  42. A V Schwartz, D E Sellmeyer, E Vittinghoff et al., “Thiazolidinedione (TZD) use and bone loss in older diabetic adults,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3349–3354, 2006. View at Publisher · View at Google Scholar
  43. A M Schott, C Cormier, D Hans et al., “How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study,” Osteoporosis International, vol. 8, no. 3, pp. 247–254, 1998. View at Publisher · View at Google Scholar
  44. H H Bolotin and H Sievänen, “Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility,” Journal of Bone and Mineral Research, vol. 16, no. 5, pp. 799–805, 2001. View at Publisher · View at Google Scholar
  45. H H Bolotin, H Sievänen, and J L Grashuis, “Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions,” Journal of Bone and Mineral Research, vol. 18, no. 6, pp. 1020–1027, 2003. View at Publisher · View at Google Scholar
  46. P Tothill, “Dual-energy X-ray absorptiometry measurements of total-body bone mineral during weight change,” Journal of Clinical Densitometry, vol. 8, no. 1, pp. 31–38, 2005. View at Publisher · View at Google Scholar
  47. D Chappard, M Moquereau, P Mercier et al., “Ex vivo bone mineral density of the wrist: influence of medullar fat,” Bone, vol. 34, no. 6, pp. 1023–1028, 2004. View at Publisher · View at Google Scholar · View at PubMed